Zeo Scientifix, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OQB
Wendy Grey and Greyt Ventures, LLC were granted a total of 1.25 million stock options in Zeo ScientifiX, Inc. on June 10, 2026.
OQB
CEO and CFO Ian Bothwell was granted 1.25 million stock options in Zeo ScientifiX, Inc. under the 2021 Equity Incentive Plan.
OQB
Chief Medical Officer George Craig Shapiro was granted 1.25 million stock options in Zeo ScientifiX, Inc.
OQB
Director Charles Luther Bretz was granted 80,000 stock options in Zeo ScientifiX, Inc. as part of the company's 2021 Equity Incentive Plan.
OQB
Zeo ScientifiX, Inc. director and 10% owner Wendy Grey was granted 175,000 restricted common shares under the company's 2021 Equity Incentive Plan.
OQB
Zeo ScientifiX, Inc.'s CEO and CFO, Ian T. Bothwell, was granted 175,000 restricted common shares under the company's 2021 Equity Incentive Plan.
OQB
Zeo ScientifiX's Chief Medical Officer, George Craig Shapiro, was granted 175,000 restricted common shares under the company's 2021 Equity Incentive Plan.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc. (ZEOX), reported the purchase of 6,000 shares of common stock on June 25, 2025, increasing its direct beneficial ownership to 416,371 shares.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc. (ZEOX), reported two open market purchases of common stock totaling 4,002 shares in mid-June 2025.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reported the acquisition of 524 shares of common stock at $2 per share, increasing its beneficial ownership to 406,369 shares.
OQB
Skycrest Holdings, LLC, a former significant shareholder of Zeo ScientifiX, Inc., has reported a direct acquisition of 138 shares of common stock at $1.99 per share.
OQB
Skycrest Holdings, a former 10% owner of Zeo ScientifiX, reported the purchase of 11,100 shares of common stock at $2 per share, increasing its direct beneficial ownership to 405,707 shares.
OQB
Skycrest Holdings, a former 10% owner of Zeo ScientifiX, reported multiple purchases of common stock totaling 3,500 shares in May 2025, increasing its direct beneficial ownership to 394,607 shares.
OQB
Wendy Grey, a director and 10% owner of Zeo ScientifiX, acquired warrants to purchase 55,000 shares of common stock.
OQB
Director Steven Jerry Glauser reports the acquisition of stock options in Zeo ScientifiX, Inc.
OQB
Chief Medical Officer George Craig Shapiro reports the acquisition of 55,000 stock options in Zeo ScientifiX, Inc. on May 8, 2025.
OQB
Director Charles Luther Bretz reports receiving two grants of stock options for Zeo ScientifiX, Inc.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., has increased its holdings through a series of open market purchases of common stock.
OQB
Director Leathem S. Stearn reports acquisition of stock options in Zeo ScientifiX, Inc.
OQB
Ian T. Bothwell, Interim CEO & CFO of Zeo ScientifiX, Inc., reports the acquisition of 55,000 stock options under the company's 2021 Equity Incentive Plan.
OQB
Gurvinder Pal Singh, a director of Zeo ScientifiX, Inc., was granted stock options to purchase shares of the company's common stock.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports acquiring 5,000 shares of common stock at $2.81 per share on May 8, 2025.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports acquiring additional shares of common stock through a series of open market purchases, increasing its direct holdings.
OQB
Skycrest Holdings, LLC, a former 10% owner, reports purchasing additional shares of Zeo ScientifiX, Inc. common stock.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports the acquisition of 1,001 shares of common stock at $2.22 per share on April 28, 2025.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports purchasing 175 shares of common stock at $2.05 per share.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports the acquisition of additional common stock.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports purchasing 2,400 shares of common stock at $1.90 per share on April 11, 2025, increasing its holdings to 325,087 shares.
OQB
Skycrest Holdings, LLC, a former 10% owner, reports purchasing additional shares of Zeo ScientifiX, Inc. common stock.
OQB
Skycrest Holdings, LLC, a former 10% owner of Zeo ScientifiX, Inc., reports the disposition of 5,000 common stock shares on February 20, 2025.